Characterization of chronic myeloid leukemia stem cells-Reference-Cited by-同舟云学术

Characterization of chronic myeloid leukemia stem cells

Published:2010-12-03 Issue:1 Volume:86 Page:31-37
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Gerber Jonathan M.,Qin Lu,Kowalski Jeanne,Smith B. Douglas,Griffin Constance A.,Vala Milada S.,Collector Michael I.,Perkins Brandy,Zahurak Marianna,Matsui William,Gocke Christopher D.,Sharkis Saul J.,Levitsky Hyam I.,Jones Richard J.

Publisher

Wiley

Subject

Hematology

Reference45 articles.

1. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia;Druker;N Engl J Med

2. High-dose imatinib mesylate therapy in newly diagnosed Philadelphia chromosome-positive chronic phase chronic myeloid leukemia;Kantarjian;Blood

3. Discontinuation of imatinib therapy after achieving a molecular response;Cortes;Blood

4. Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years;Rousselot;Blood

5. Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro;Graham;Blood

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stem Cell Responsiveness to Imatinib in Chronic Myeloid Leukemia;International Journal of Molecular Sciences;2023-11-23

2. Preferentially Expressed Antigen in Melanoma Is a Multifaceted Cancer Testis Antigen with Diverse Roles as a Biomarker and Therapeutic Target;International Journal of Translational Medicine;2023-08-29

3. Therapy Resistance and Disease Progression in CML: Mechanistic Links and Therapeutic Strategies;Current Hematologic Malignancy Reports;2022-10-19

4. Peripheral blood marker of residual acute leukemia after hematopoietic cell transplantation using multi-plex digital droplet PCR;Frontiers in Immunology;2022-09-29

5. Isolation, Maintenance and Expansion of Adult Hematopoietic Stem/Progenitor Cells and Leukemic Stem Cells;Cancers;2022-03-28